Outcomes of Retesting in Patients with Previously Uninformative Cancer Genetics Evaluations

PURPOSE: Advances in cancer genetics have increased germline pathogenic/likely pathogenic variant (PV/LPV) detection rates. More data is needed to inform which patients with previously uninformative results could benefit most from retesting, especially beyond breast/ovarian cancer populations. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dettwyler, Shenin A., Koeppe, Erika S., Jacobs, Michelle F., Stoffel, Elena M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934750/
https://www.ncbi.nlm.nih.gov/pubmed/34545504
http://dx.doi.org/10.1007/s10689-021-00276-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934750/
https://www.ncbi.nlm.nih.gov/pubmed/34545504
http://dx.doi.org/10.1007/s10689-021-00276-8

Ejemplares similares